Ted Karkus - Oct 16, 2022 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role: CEO & CHAIRMAN, Director, 10%+ Owner
Signature: /s/ Ted Karkus
Stock symbol: PRPH
Transactions as of: Oct 16, 2022
Transactions value $: -$2,942,999
Form type: 4
Date filed: 10/18/2022, 09:34 AM
Previous filing: Aug 10, 2022
Next filing: Jan 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRPH	Common Stock, par value $0.005	Options Exercise	$360K	+600K	+21.52%	$0.60^*	3.39M	Oct 16, 2022	Direct	F1
transaction	PRPH	Common Stock, par value $0.005	Tax liability	-$3.3M	-317K	-9.36%	$10.41	3.07M	Oct 16, 2022	Direct	F1
holding	PRPH	Common Stock, par value $0.005						100K	Oct 16, 2022	By Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRPH	Option (right to buy)	Options Exercise	$0	-600K	-35.29%	$0.00	1.1M	Oct 16, 2022	Common Stock	600K	$0.60	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 16, 2022, the Reporting Person acquired net 282,709 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 317,291 shares of common stock withheld to cover the exercise price and applicable taxes.
F2	The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.